Lir Life Sciences Corp. (CVE:SKNY) | WebDisclosure

Basculer en Français

9888	Companies
199064	Keywords
129996	Articles
105819	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

BRIEF

published on 02/06/2026 at 00:05, 12 days 22 hours ago

LIR Life Sciences lance la phase 2 de la conception de peptides avec Neuland Laboratories

Administration Transdermique LIR Sciences De La Vie Laboratoires Neuland Conception De Peptides Relations Structure-activité
BRIEF

published on 02/06/2026 at 00:05, 12 days 22 hours ago

LIR Life Sciences Initiates Phase 2 Peptide Design with Neuland Laboratories

Transdermal Delivery LIR Life Sciences Neuland Laboratories Peptide Design Structure-Activity Relationships
PRESS RELEASE

published on 02/06/2026 at 00:00, 12 days 22 hours ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
LIR Life Sciences Corp. announces commencement of Project Phase 2 peptide design activities with Neuland Laboratories Limited, focusing on next-generation cell-penetrating peptides for transdermal delivery platform optimization

Transdermal Delivery Lir Life Sciences Corp. Peptide Design Project Phase 2 Neuland Laboratories Limited
BRIEF

published on 01/30/2026 at 00:05, 19 days 22 hours ago

LIR Life Sciences annonce des résultats précliniques intermédiaires prometteurs

Administration Transdermique Résultats Précliniques Thérapies GLP/GIP Technologie CPP Contrôle De La Glycémie
BRIEF

published on 01/30/2026 at 00:05, 19 days 22 hours ago

LIR Life Sciences Reports Promising Interim Preclinical Results

Transdermal Delivery Preclinical Results GLP/GIP Therapies CPP Technology Blood Glucose Control
PRESS RELEASE

published on 01/30/2026 at 00:00, 19 days 22 hours ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
LIR Life Sciences Corp. announces positive interim results from a mouse study on CPP-enabled, needle-free delivery of GLP/GIP therapies, demonstrating glucose control potential

Interim Results Lir Life Sciences Corp. GLP/GIP Therapies CPP-enabled Delivery Skin-applied Formulation
BRIEF

published on 01/23/2026 at 00:05, 26 days 22 hours ago

LIR Life Sciences Finalizes Study Design for Evaluating Transdermal Agents

Transdermal Delivery LIR Life Sciences Therapeutic Macromolecules Porcine Skin Model Needle-free Therapies
BRIEF

published on 01/23/2026 at 00:05, 26 days 22 hours ago

LIR Life Sciences finalise le protocole d'étude pour l'évaluation des agents transdermiques

Administration Transdermique LIR Sciences De La Vie Macromolécules Thérapeutiques Modèle De Peau De Porc Thérapies Sans Aiguilles
PRESS RELEASE

published on 01/23/2026 at 00:00, 26 days 22 hours ago

LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
LIR Life Sciences Corp. announces study design for transdermal penetration of therapeutic macromolecules using ex vivo porcine skin. Focus on needle-free delivery strategies for larger therapeutics

Needle-free Delivery LIR Life Sciences Therapeutic Macromolecules Transdermal Penetration Ex Vivo Porcine Skin
BRIEF

published on 01/16/2026 at 00:05, 1 month 2 days ago

LIR Life Sciences Initiates Animal Study on Transdermal Obesity Therapies

Transdermal Delivery Obesity Therapy Animal Study LIR Life Sciences GLP/GIP-based

Accesswire

Published on 02/18/2026 at 22:00, 34 minutes ago

Nextech3D.ai Delivers Q3 +59% YoY Revenue Growth and +20% Sequential Gain With Record 95% Gross Margins; Operating Loss Improved by 46% ($696K) As Company Enters New AI‑Driven Growth Cycle
Published on 02/18/2026 at 19:10, 3 hours 24 minutes ago

Secure Blockchain Announces Definitive Agreement to Acquire Agentic Solutions Limited, Private Placement and Debt Settlement
Published on 02/18/2026 at 15:15, 7 hours 19 minutes ago

Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 7 hours 34 minutes ago

Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 8 hours 9 minutes ago

Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular

View all ACCESSWIRE

EQS Group

Published on 02/18/2026 at 22:20, 14 minutes ago

Amrize Closes Acquisition of PB Materials; Aggregates Leader in High-Growth West Texas
Published on 02/18/2026 at 22:15, 19 minutes ago

Amrize Files Form 10-K for Fiscal Year 2025
Published on 02/18/2026 at 21:01, 1 hour 32 minutes ago

North Peak Announces Increase in Size of Its Non-Brokered Private Placement
Published on 02/18/2026 at 21:00, 1 hour 34 minutes ago

HHLA records solid growth in an uncertain environment – tax-related one-off effects weigh heavily on net profit
Published on 02/18/2026 at 20:59, 1 hour 35 minutes ago

EQS-Adhoc: Hamburger Hafen und Logistik AG: HHLA records solid growth in an uncertain environment – tax-related one-off effects weigh heavily on net profit

Les Echos

Published on 02/18/2026 at 18:00, 4 hours 34 minutes ago

Publication du nombre d’actions composant le capital et du nombre total de droits de vote au 31 janvier 2026
Published on 02/18/2026 at 18:00, 4 hours 34 minutes ago

Outstanding Shares and Voting Rights Statement at 31 January 2026
Published on 02/18/2026 at 17:45, 4 hours 49 minutes ago

Chiffre d'affaires annuelle
Published on 02/18/2026 at 17:40, 4 hours 54 minutes ago

GROUPE ES - Communiqué sur les résultats 2025
Published on 02/18/2026 at 13:45, 8 hours 49 minutes ago

NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède

View all LES ECHOS COMFI WIRE